| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $253.8M | +35.1% |
| Cost of Revenue | $59.9M | +27.9% |
| Gross Profit | $194.0M | +37.5% |
| R&D Expense | $61.4M | +53.4% |
| SG&A Expense | $60.5M | +34.7% |
| Operating Income | -$51.7M | -84.0% |
| Interest Expense | $153K | -49.0% |
| Pre-tax Income | -$49.9M | -75.1% |
| Income Tax | $366K |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $79.9M | -25.4% |
| Accounts Receivable | $35.8M | +40.6% |
| Current Assets | $235.5M | +5.8% |
| Total Assets | $293.9M | +11.0% |
| Current Liabilities | $132.8M | +34.9% |
| Total Liabilities | $151.6M | +26.8% |
| Stockholders' Equity | $142.3M | -2.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $10.7M | -28.0% |
| Capital Expenditures | $1.8M | +97.0% |
| Investing Cash Flow | -$37.7M | -70.3% |
| Financing Cash Flow | -$193K | -93.0% |
| Free Cash Flow | $8.8M | -36.3% |
| +73.5% |
| Net Income | -$50.2M | -75.0% |
| EPS (Diluted) | -$0.92 | -73.6% |